PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
Part of paid clinical trials in Falls Church, Virginia.
- Sponsor
- Inova Health Care Services
- Study ID
- NCT05433220
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Best Practice Advisory using Electronic Health Record — OTHERProviders caring for patients randomized to the intervention arm will have a best practice alert appear for each of their eligible patients upon opening of the order entry screen in the patient's medical record. This alert informs the provider to the presence of HFrEF, notes the patient's current LVEF and current evidence-based medications, and gives access to an order set with recommended evidence- based, guideline-recommended, and FDA- approved therapies for patients with HFrEF. Providers will also have access to a link to best available guideline recommended information regarding treatment of heart failure to allow further education if desired by the provider. The alerts will also clearly state the expected monitoring and follow-up required for prescriptions of these medications.
Study Details
A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure versus usual care (no alert and how things are done currently). The purpose of the alert is to stimulate appropriate medication prescription for patients with heart failure and a reduced ejection fraction. This will be done across outpatient Inova clinics and at the five Inova hospitals.
Key Dates
- Start date
- Aug 25, 2022
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 5,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Alert when provider is entering orders
- No Intervention: No alert, usual care
Primary Outcome Measure
Increased use of GDMT in patients with Heart Failure with Reduced Ejection Fraction [ Time Frame: 30 days after randomization ]
Central Contacts
- Matthew G Dimond, BS7037762828
- Bhruga Shah, MS, BSN-RN7037762828
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Inova Health System | Falls Church | Virginia | 22042 |
Find similar trials in Falls Church, VA
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Global Utilization And Registry Database for Improved heArt preservatioNEnrolling By Invitation · Paragonix Technologies · Stanford, California
- Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock TrialRecruiting · Inova Health Care Services · Falls Church, Virginia